Cost and Management of Asthma Exacerbations in Spanish Hospitals (COAX Study in Hospital Services)

Clau, Luis Borderías; Murguionda, M. Zabaleta; Miranda, José; Ciscar, C. Pellicer; Hernández, Juan Ramón Hernández; Díaz, T. Carrillo; García, Gabriel

doi:10.1016/s1579-2129(06)60239-5

Cited by 14 publications

(14 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, some of the reviewed cost-of-illness studies estimated the healthcare costs associated with asthma, but they took the broader societal perspective and also included the impact of morbidity and mortality on employment, productivity and other social costs. In five studies, the indirect costs greatly exceeded the direct costs [ 13 , 17 , 22 , 51 , 52 ]. The quality of all but one of the above studies was also high [ 51 ] and indirect costs accounted for 52–75% of the overall costs (Table 4 ).…”

Section: Resultsmentioning

confidence: 99%

Economic burden of asthma: a systematic review

et al. 2009

View full text Add to dashboard Cite

BackgroundAsthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.MethodsWe performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.ResultsSixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.ConclusionDespite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

show abstract

Section: Resultsmentioning

confidence: 99%

Economic burden of asthma: a systematic review

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Representing one of them, COAX study was conducted with more than 2000 subjects from fifteen countries and reported the cost of asthma attack to be V445 in primary and V1349 in secondary care centers with the cost of V737 for mild attack, while V881 and V1074 for moderate and severe attacks. 10 Notably, there are no studies concerning cost per asthma attack in primary and secondary care in our country. Therefore, while cost per asthma attack in primary and secondary care in other countries seems immensely higher when compared to cost per attack in tertiary care across Turkey, the data from different countries may not be comparable due to significant differences between countries in terms of health policies as well as the disease management.…”

Section: Discussionmentioning

confidence: 96%

A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey

Bavbek

Mungan

Türktaş

et al. 2011

Respiratory Medicine

View full text Add to dashboard Cite

show abstract

“…Nevertheless, in Europe and Korea it is the outpatient medication and human resources that are responsible for most of the direct costs [10, 28, 34, 35]. …”

Section: Introductionmentioning

confidence: 99%

Asthma costs and social impact

Nunes¹,

Pereira

Morais‐Almeida

2017

asthma res and pract

615

394

View full text Add to dashboard Cite

In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle risk factors.In many countries noncommunicable diseases, like asthma, are not yet considered a healthcare priority. This review will analyze and discuss disparities in asthma management in several countries and regions, such as access to healthcare human resources and medications, due to limited financial capacity to develop strategies to control and prevent this chronic disease.This review tries to explore the social and economic burden of asthma impact on society. Although asthma is generally accepted as a costly illness, the total costs to society (direct, indirect and intangible asthma costs) are difficult to estimate, mainly due to different disease definitions and characterizations but also to the use of different methodologies to assess the asthma socio-economic impact in different societies.The asthma costs are very variables from country to country, however we can estimate that a mean cost per patient per year, including all asthmatics (intermittent, mild, moderate and severe asthma) in Europe is $USD 1,900, which seems lower than USA, estimated mean $USD 3,100.

show abstract

Cost and Management of Asthma Exacerbations in Spanish Hospitals (COAX Study in Hospital Services)

Cited by 14 publications

References 25 publications

Economic burden of asthma: a systematic review

Economic burden of asthma: a systematic review

A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey

Asthma costs and social impact

Contact Info

Product

Resources

About